D. Lerouge

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial

C. Le Péchoux, Ariane Dunant, Suresh Senan et al. · The Lancet Oncology · 2009 · 342 citations

Adaptive Radiotherapy, Radiation Medicine, Radiation Therapy +10

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

C. Le Péchoux, A. Laplanche, Corinne Faivre‐Finn et al. · Annals of Oncology · 2010 · 186 citations · Full text

Neuro-oncology, Clinical Neurological Outcome, Radiation Therapy +11

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma

Laurence Moureau-Zabotto, E. Touboul, D. Lerouge et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 132 citations

Positron Emission Tomography, Esophageal Cancer, Medical Imaging +9

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non–small-cell lung cancer

Élisabeth Deniaud-Alexandre, E. Touboul, D. Lerouge et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 121 citations

Computed Tomography, Non–small-cell Lung Cancer, Oncologic Imaging +12

LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683

C. Le Péchoux, N. Pourel, Fabrice Barlési et al. · Annals of Oncology · 2020 · 93 citations · Full text

International Randomized Trial, Surgical Oncology, Radiation Medicine +11